Clinical Trials Logo

Clinical Trial Summary

OBJECTIVES:

I. Assess the efficacy of thioctic acid in treating a single patient with mitochondrial myopathy.


Clinical Trial Description

PROTOCOL OUTLINE: The patient receives one thioctic acid tablet 3 times a day. If patient experiences no side effects after 1 week, 2 tablets are administered and given 3 times a day over 3 months for compassionate use.

The patient is followed at weeks 3, 8, and 12. ;


Study Design

Endpoint Classification: Efficacy Study, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00004770
Study type Interventional
Source Office of Rare Diseases (ORD)
Contact
Status Completed
Phase N/A
Start date October 1995

See also
  Status Clinical Trial Phase
Completed NCT02895789 - Oxidative Capacity and Exercise Tolerance in Ambulatory SMA
Recruiting NCT05590468 - A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy Phase 2
Recruiting NCT00457314 - The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease Phase 2
Completed NCT02367014 - Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy Phase 1/Phase 2
Completed NCT00004353 - Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia N/A